Oncology research today is more dynamic than ever with protocol designs that range from simple to some of the most complex studies that often span many countries globally. 

Oncology Complete combines Signant's integrated technology solutions with in-house scientific and operational expertise – all under one contract and one project team  to simplify the patient experience and streamline trial operations for any oncology study or program.   

PROOF AT THE SPEED OF LIFE

BETTER TRIALS, GREATER SUCCESS  

A COMPREHENSIVE TECHNOLOGY FRAMEWORK AND SCIENTIFIC EXPERTISE, BUILT ON 20+ YEARS’ EXPERIENCE 

Connect With UsDownload Overview

ONCOLOGY COMPLETE

SIGNANT ONCOLOGY EXPERIENCE

RESOURCES

Streamline the consenting process for patients including bio-sample collection and mid-study re-consenting  

Manage randomization and study supplies efficiently, even for the most complex study design, including platform, basket, and adaptive trials 

Capture data from patients at-home or during site visits, guide them through each step of the study, and simply mid-visit and long-term follow up

Signant Health is the evidence generation company. We are focused on leveraging software, deep therapeutic and scientific knowledge, and operational expertise to consistently capture, aggregate, and reveal quality evidence for clinical studies across traditional, virtual, and hybrid trial models. For more than 20 years, over 400 sponsors and CROs of all sizes – including all Top 20 pharma – have trusted Signant solutions for remote and site-based eCOA, eConsent, RTSM, supply chain management, and data quality analytics. 

eCONSENT

RTSM

eCOA, ENGAGEMENT, VIDEO VISITS

Single patient app for simplified study experience  

Integrated data for easier workflow

INTEGRATED SOLUTIONS, IMPROVED EXPERIENCE

SIMPLIFY PATIENT EXPERIENCE

OPTIMIZE SITE WORKFLOWS

SIMPLIFY STUDY TEAM ACTIVITY 

Work with a single project manager, single contract, and single helpdesk 

 Learn more about Oncology Complete by downloading the brochure and contacting our oncology research specialists.

Press Release